Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment

Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment

Background/Aims: Disease-modifying therapy for Alzheimer’s disease (AD) has led to a need for biomarkers to identify prodromal AD and very early stage of AD dementia. We aimed to identify the cutoff values of cerebrospinal fluid (CSF) biomarkers for detecting prodromal AD. Methods: We assessed 56 pa...

Full description

Bibliographic Details
Main Authors: Jung Eun Park, Kyu Yeong Choi, Byeong C. Kim, Seong-Min Choi, Min-Kyung Song, Jang Jae Lee, Jahae Kim, Ho-Chun Song, Hoo-Won Kim, Jung-Min Ha, Eun Hyun Seo, Woo Keun Song, Sung-Gyoo Park, Jung Sup Lee, Kun Ho Lee
Format: Article
Language:English
Published: Karger Publishers 2019-03-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Alzheimer’s disease
Prodromal Alzheimer’s disease
Mild cognitive impairment
Cerebrospinal fluid
Beta-amyloid
Biomarkers
Online Access:https://www.karger.com/Article/FullText/496920

Internet

https://www.karger.com/Article/FullText/496920

Similar Items